Cargando…

RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer

The receptor for advanced glycation end products (RAGE) is implicated in diabetes and obesity complications, as well as in breast cancer (BC). Herein, we evaluated whether RAGE contributes to the oncogenic actions of Insulin, which plays a key role in BC progression particularly in obese and diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muoio, M. G., Pellegrino, M., Rapicavoli, V., Talia, M., Scavo, G., Sergi, V., Vella, V., Pettinato, S., Galasso, M. G., Lappano, R., Scordamaglia, D., Cirillo, F., Pulvirenti, A., Rigiracciolo, D. C., Maggiolini, M., Belfiore, A., De Francesco, E. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351154/ https://www.ncbi.nlm.nih.gov/pubmed/37461077 http://dx.doi.org/10.1186/s13058-023-01686-5

Ejemplares similares

Publisher Correction: RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer
por: Muoio, M. G., et al.
Publicado: (2023)

Activation of the S100A7/RAGE Pathway by IGF-1 Contributes to Angiogenesis in Breast Cancer
por: Muoio, Maria Grazia, et al.
Publicado: (2021)

IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2020)

Correction: Rigiracciolo, D.C., et al., IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells. Cells 2020, 9, 1010
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2020)

The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs)
por: Lappano, Rosamaria, et al.
Publicado: (2020)

The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells
por: Santolla, Maria Francesca, et al.
Publicado: (2022)

Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts
por: Cirillo, Francesca, et al.
Publicado: (2021)

Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC)
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2022)

SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer
por: Santolla, M F, et al.
Publicado: (2015)

Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells
por: Scordamaglia, Domenica, et al.
Publicado: (2022)

The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis
por: Talia, Marianna, et al.
Publicado: (2020)

The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells
por: Talia, Marianna, et al.
Publicado: (2023)

Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2021)

Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling
por: Vella, Veronica, et al.
Publicado: (2020)

GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway
por: Cirillo, Francesca, et al.
Publicado: (2023)

GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression
por: Santolla, Maria Francesca, et al.
Publicado: (2019)

The lauric acid-activated signaling prompts apoptosis in cancer cells
por: Lappano, Rosamaria, et al.
Publicado: (2017)

COVID-19 and Diabetes: The Importance of Controlling RAGE
por: De Francesco, Ernestina M., et al.
Publicado: (2020)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2019)

IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?
por: Belfiore, Antonino, et al.
Publicado: (2023)

Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells
por: Avino, Silvia, et al.
Publicado: (2016)

Copper activates HIF-1α/GPER/VEGF signalling in cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2015)

DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System
por: Vella, Veronica, et al.
Publicado: (2021)

Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
por: Vella, Veronica, et al.
Publicado: (2023)

miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs)
por: Vivacqua, Adele, et al.
Publicado: (2018)

GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer
por: Cirillo, Francesca, et al.
Publicado: (2017)

miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling
por: Santolla, Maria Francesca, et al.
Publicado: (2018)

Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
por: Vella, Veronica, et al.
Publicado: (2021)

Role of the G Protein-Coupled Receptors in Cancer and Stromal Cells: From Functions to Novel Therapeutic Perspectives
por: Lappano, Rosamaria, et al.
Publicado: (2023)

RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
por: Kang, R, et al.
Publicado: (2014)

Response to “Comment on ‘Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts’”
por: Lappano, Rosamaria, et al.
Publicado: (2016)

GPER Function in Breast Cancer: An Overview
por: Lappano, Rosamaria, et al.
Publicado: (2014)

GPCR Modulation in Breast Cancer
por: Lappano, Rosamaria, et al.
Publicado: (2018)

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014)

GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2015)

Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells
por: De Marco, Paola, et al.
Publicado: (2015)

Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells
por: Iacopetta, Domenico, et al.
Publicado: (2020)

Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling
por: Rai, Vivek, et al.
Publicado: (2012)

RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer
por: Chen, Mei-Chih, et al.
Publicado: (2020)

G-Protein-Coupled Estrogen Receptor Expression in Rat Uterine Artery Is Increased by Pregnancy and Induces Dilation in a Ca(2+) and ERK1/2 Dependent Manner
por: Tropea, Teresa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h13un16rdfn4qov8sjh4aju02j